Related Experiment Videos
[Transfusion policy toward a patient with an anti-Cartwright antibody (anti-Yta)]
F Arriaga1, R García, M Guinot
1Servicio de Hematología y Hemoterapia, Hospital Universitario La Fe, Valencia.
Sangre
|August 1, 1993
We have observed one patient with hepatic cirrhosis showing on her antibody screening an anti-Yta. We studied the 51 Cr-labelled erythrocyte survival using either Yt (a+) and autologous blood red cells. She was transfused two Yt (a+) red blood cell concentrates without any adverse reaction.
We have observed one patient with hepatic cirrhosis showing on her antibody screening an anti-Yta. We studied the 51 Cr-labelled erythrocyte survival using either Yt (a+) and autologous blood red cells. She was transfused two Yt (a+) red blood cell concentrates without any adverse reaction.